aHUS Observational Long Term Follow-Up

Stopped early

Conditions studied: Atypical Hemolytic Uremic Syndrome

In brief

There is growing but limited information on the long term clinical status of aHUS patients who have previously received or are continuing to receive treatment with eculizumab. This study is designed to collect clinical data that will provide insight into the long-term outcomes of patients with aHUS.

Key facts

Study ID
NCT01522170
Run by
Alexion Pharmaceuticals, Inc.
People needed
94
Starts
2012-03-01
Expected to finish
2017-01-01
Last updated by the study team
2017-02-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.